Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Increases Lactobacillus - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
📓
Effect and Mechanism of Pharmaceutical Excipients on Berberine to Alleviate Ulcerative Colitis via Regulating Gut Microbiota. Molecules (Basel, Switzerland) (Molecules ) Vol: 27 Issue 18 Pages: Pub: 2022 Sep 15 Epub: 2022 Sep 15 Authors Wu C , Zheng T , Chen H , Zou P , Zhang M , Wang J , Li N , Zhang Y , Li Y , Dong Z , Html Article Publication |
| Increases Lactobacillus - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
📓
Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota. Nutrients (Nutrients ) Vol: 14 Issue 4 Pages: Pub: 2022 Feb 9 Epub: 2022 Feb 9 Authors Deng J , Zhao L , Yuan X , Li Y , Shi J , Zhang H , Zhao Y , Han L , Wang H , Yan Y , Zhao H , Wang H , Zou F , Html Article Publication |
| Increases Lactobacillus - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
📓
Berberine ameliorates aGVHD by gut microbiota remodelling, TLR4 signalling suppression and colonic barrier repairment for NLRP3 inflammasome inhibition. Journal of cellular and molecular medicine (J Cell Mol Med ) Vol: 26 Issue 4 Pages: 1060-1070 Pub: 2022 Feb Epub: 2022 Jan 5 Authors Zhao Y , Huang J , Li T , Zhang S , Wen C , Wang L , Html Article Publication |
| Increases Lactobacillus - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
📓
Microbiome and metabolome analyses reveal significant alterations of gut microbiota and bile acid metabolism in ETEC-challenged weaned piglets by dietary berberine supplementation. Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1428287 Pub: 2024 Epub: 2024 Jun 25 Authors Nie X , Lu Q , Yin Y , He Z , Bai Y , Zhu C , Html Article Publication |
| Increases Lactobacillus - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
📓
Berberine alleviates ischemia reperfusion injury induced AKI by regulation of intestinal microbiota and reducing intestinal inflammation. BMC complementary medicine and therapies (BMC Complement Med Ther ) Vol: 24 Issue 1 Pages: 66 Pub: 2024 Jan 30 Epub: 2024 Jan 30 Authors Huo A , Wang F , Html Article Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
